Skip to main content
. 2008 Sep 3;2(4):405–415. doi: 10.1007/s12072-008-9093-y

Fig. 2.

Fig. 2

Schematic diagram outlining the major parameters affecting the severity of liver fibrosis and the major points at which potential anti-fibrogenic therapeutics intervene. Numbers refer to numbering for “mode of action” as given in Table 1. Inhibition, T; promoters, ↑